Use of oral anticoagulants in African-American and Caucasian patients with atrial fibrillation: is there a treatment disparity?

References

• American Heart AssociationWhat is atrial fibrillation?2013 Available from: http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300294.pdfAccessed October 30, 2013
   Google Scholar
• FurieKLGoldsteinLBAlbersGWOral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke AssociationStroke201243123442345322858728
   PubMed Web of Science ®Google Scholar
• YouJJSingerDEHowardPAAntithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 Supple531Se575S22315271
   PubMed Web of Science ®Google Scholar
• AlonsoAAgarwalSKSolimanEZIncidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) studyAm Heart J2009158111111719540400
   PubMed Web of Science ®Google Scholar
• FusterVRydénLECannomDS2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelinesCirculation201112310e269e36721382897
   PubMed Web of Science ®Google Scholar
• CammAJLipGYDe CaterinaR2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm AssociationEur Heart J201233212719274722922413
   PubMed Web of Science ®Google Scholar
• GoASMozaffarianDRogerVLHeart disease and stroke statistics – 2013 update: a report from the American Heart AssociationCirculation20131271e6e24523239837
   PubMed Web of Science ®Google Scholar
• FurieKLKasnerSEAdamsRJGuidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationStroke201142122727620966421
   PubMed Web of Science ®Google Scholar
• MariniCDeSFSaccoSContribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based studyStroke20053661115111915879330
   PubMed Web of Science ®Google Scholar
• SudlowCLWarlowCPComparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence CollaborationStroke19972834914999056601
   PubMed Web of Science ®Google Scholar
• GageBFWatermanADShannonWBoechlerMRichMWRadfordMJValidation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial FibrillationJAMA2001285222864287011401607
   PubMed Web of Science ®Google Scholar
• LipGYNieuwlaatRPistersRLaneDACrijnsHJRefining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial FibrillationChest2010137226327219762550
   PubMed Web of Science ®Google Scholar
• BenjaminEJWolfPAD’AgostinoRBSilbershatzHKannelWBLevyDImpact of atrial fibrillation on the risk of death: the Framingham Heart StudyCirculation199898109469529737513
   PubMed Web of Science ®Google Scholar
• LinHJWolfPAKelly-HayesMStroke severity in atrial fibrillation. The Framingham StudyStroke19962710176017648841325
   PubMed Web of Science ®Google Scholar
• FusterVRydénLECannomDSACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyCirculation20061147e257e35416908781
   PubMed Web of Science ®Google Scholar
• DeitelzweigSAminAJingYMedical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF and ARISTOTLE trialsJ Med Econ201215477678522449118
   PubMedGoogle Scholar
• GoldsteinLBBushnellCDAdamsRJGuidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationStroke201142251758421127304
   PubMed Web of Science ®Google Scholar
• MeschiaJFMerrillPSolimanEZRacial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) studyStroke201041458158720190000
   PubMed Web of Science ®Google Scholar
• SmithSCJrClarkLTCooperRSDiscovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing GroupCirculation200511110e134e13915769755
   PubMed Web of Science ®Google Scholar
• SolimanEZPrineasRJCaseLDZhangZMGoffDCJrEthnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) studyStroke20094041204121119213946
   PubMed Web of Science ®Google Scholar
• WhiteHBoden-AlbalaBWangCIschemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan StudyCirculation2005111101327133115769776
   PubMed Web of Science ®Google Scholar
• PrineasRJSolimanEZHowardGThe sensitivity of the method used to detect atrial fibrillation in population studies affects group-specific prevalence estimates: ethnic and regional distribution of atrial fibrillation in the REGARDS studyJ Epidemiol200919417718119561382
   PubMed Web of Science ®Google Scholar
• JensenPNThackerELDublinSPsatyBMHeckbertSRRacial differences in the incidence of and risk factors for atrial fibrillation in older adults: the Cardiovascular Health StudyJ Am Geriatr Soc201361227628023320758
   PubMed Web of Science ®Google Scholar
• Kolominsky-RabasPLWeberMGefellerONeundoerferBHeuschmannPUEpidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based studyStroke200132122735274011739965
   PubMed Web of Science ®Google Scholar
• LeeBINamHSHeoJHKimDIYonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctionsCerebrovasc Dis200112314515111641577
   PubMed Web of Science ®Google Scholar
• PettyGWBrownRDJrWhisnantJPSicksJDO’FallonWMWiebersDOIschemic stroke subtypes: a population-based study of incidence and risk factorsStroke199930122513251610582970
   PubMed Web of Science ®Google Scholar
• SaccoRLEllenbergJHMohrJPInfarcts of undetermined cause: the NINCDS Stroke Data BankAnn Neurol19892543823902712533
   PubMed Web of Science ®Google Scholar
• SchneiderATKisselaBWooDIschemic stroke subtypes: a population-based study of incidence rates among blacks and whitesStroke20043571552155615155974
   PubMed Web of Science ®Google Scholar
• SchulzUGRothwellPMDifferences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studiesStroke20033482050205912829866
   PubMed Web of Science ®Google Scholar
• ChristensenLMKriegerDWHøjbergSParoxysmal atrial fibrillation occurs often in cryptogenic ischaemic stroke. Final results from the SURPRISE studyEur J Neurol201421688488924628954
   PubMed Web of Science ®Google Scholar
• AndersonJLHalperinJLAlbertNMManagement of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol201361181935194423558044
   PubMed Web of Science ®Google Scholar
• FergusonCInglisSCNewtonPJMiddletonSMacdonaldPSDavidsonPMAtrial fibrillation: stroke prevention in focusAust Crit Care2014272929824054541
   PubMed Web of Science ®Google Scholar
• JanuaryCTWannLSAlpertJS2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm SocietyJ Am Coll Cardiol2014642122462280
   Web of Science ®Google Scholar
• MeschiaJFBushnellCBoden-AlbalaBGuidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke AssociationStroke201445123754383225355838
   PubMed Web of Science ®Google Scholar
• CammAJKirchhofPLipGYGuidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)Eur Heart J201031192369242920802247
   PubMed Web of Science ®Google Scholar
• IbrahimSAKwohCKHarperDLBakerDWRacial differences in the utilization of oral anticoagulant therapy in heart failure: a study of elderly hospitalized patientsJ Gen Intern Med200015213413710672118
   PubMed Web of Science ®Google Scholar
• SchwammLHReevesMJPanWRace/ethnicity, quality of care, and outcomes in ischemic strokeCirculation2010121131492150120308617
   PubMed Web of Science ®Google Scholar
• ShenAYYaoJFBrarSSJorgensenMBWangXChenWRacial/ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillationStroke200839102736274318635860
   PubMed Web of Science ®Google Scholar
• ApostolakisSSullivanRMOlshanskyBLipGYFactors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT(2)R(2) scoreChest201314451555156323669885
   PubMed Web of Science ®Google Scholar
• Henry J Kaiser Family FoundationExamining sources of supplemental insurance and prescription coverage among Medicare beneficiaries; findings from the Medicare Current Beneficiary Survey2007 Available from: http://kff.org/medicare/report/examining-sources-of-supplemental-insurance-and-prescriptionAccessed December 9, 2014
   Google Scholar
• HanchateADSchwammLHHuangWHylekEMComparison of is chemic stroke outcomes and patient and hospital characteristics by race/ethnicity and socioeconomic statusStroke201344246947623306327
   PubMed Web of Science ®Google Scholar
• BhattacharyaPMadaFSalowich-PalmLAre racial disparities in stroke care still prevalent in certified stroke centers?J Stroke Cerebrovasc Dis201322438338822078781
   PubMed Web of Science ®Google Scholar
• SaccoRLKargmanDEZamanilloMCRace-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarction: the Northern Manhattan Stroke StudyNeurology19954546596637723951
   PubMed Web of Science ®Google Scholar
• HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med20071461285786717577005
   PubMed Web of Science ®Google Scholar
• Bristol-Myers SquibbCoumadin [prescribing information]2011 Available from: http://packageinserts.bms.com/pi/pi_coumadin.pdfAccessed October 11, 2013
   Google Scholar
• RosenmanMBSimonTATealEMcGuirePNisiDJacksonJDPerceived or actual barriers to warfarin use in atrial fibrillation based on electronic medical recordsAm J Ther201219533033722964558
   PubMed Web of Science ®Google Scholar
• DangMTHambletonJKayserSRThe influence of ethnicity on warfarin dosage requirementAnn Pharmacother20053961008101215855242
   PubMed Web of Science ®Google Scholar
• GarwoodCLClementeJLIbeGNKandulaVACurtisKDWhittakerPWarfarin maintenance dose in older patients: higher average dose and wider dose frequency distribution in patients of African ancestry than those of European ancestryBlood Cells Mol Dis2010451939720418129
   PubMed Web of Science ®Google Scholar
• Birman-DeychERadfordMJNilasenaDSGageBFUse and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillationStroke20063741070107416528001
   PubMed Web of Science ®Google Scholar
• SchauerDPJohnstonJAMoomawCJWessMEckmanMHRacial disparities in the filling of warfarin prescriptions for nonvalvular atrial fibrillationAm J Med Sci20073332677317301583
   PubMed Web of Science ®Google Scholar
• ThomasKLPicciniJPLiangLRacial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failureJ Am Heart Assoc201325e00020024072530
   PubMed Web of Science ®Google Scholar
• ShenAYYaoJFBrarSSJorgensenMBChenWRacial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillationJ Am Coll Cardiol200750430931517659197
   PubMed Web of Science ®Google Scholar
• CavallariLHAstonJLMomaryKMShapiroNLPatelSRNutescuEAPredictors of unstable anticoagulation in African AmericansJ Thromb Thrombolysis200927443043718563532
   PubMed Web of Science ®Google Scholar
• PereraMACavallariLHLimdiNAGenetic variants associated with warfarin dose in African-American individuals: a genome-wide association studyLancet2013382989479079623755828
   PubMed Web of Science ®Google Scholar
• LimdiNABeasleyTMCrowleyMRVKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-AmericansPharmacogenomics20089101445145818855533
   PubMed Web of Science ®Google Scholar
• LimdiNAArnettDKGoldsteinJAInfluence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-AmericansPharmacogenomics20089551152618466099
   PubMed Web of Science ®Google Scholar
• Daiichi Sankyo Co. LtdSavaysa™ (edoxaban) prescribing information2015 Available from http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206316lbl.pdfAccessed January 22, 2015
   Google Scholar
• Boehringer IngelheimPradaxa dabigatran etexilate capsules [prescribing information] Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022512s017lbl.pdfAccessed September 18, 2013
   Google Scholar
• Bristol-Myers SquibbEliquis^® (apixaban tablets) [prescribing information]2014 Available from: http://packageinserts.bms.com/pi/pi_eliquis.pdfAccessed March 20, 2014
   Google Scholar
• Janssen PharmaceuticalsXarelto^® (rivaroxaban tablets) [prescribing information]2014 Available from: http://www.xareltohcp.com/sitesdefault/files/pdf/xarelto_0.pdf#zoom=100Accessed March 8, 2014
   Google Scholar
• SongYWangXPerlsteinIBioavailability of apixaban solution formulation and crushed tablet via nasogastric tubeClin Pharmacol Ther201393Suppl 1S120S121
   Google Scholar
• Boehringer IngelheimStudy to evaluate the safety, pharmacokinetics and pharmacodynamics of BI 655075 administered alone or with dabigatran etexilate Available from: http://clinicaltrials.gov/show/NCT01688830. NLM identifier: NCT01688830Accessed June 6, 2013
   Google Scholar
• CrowtherMKittMLorenzTA phase 2 randomized, double-blind, placebo-controlled trial of PRT064445, a novel, universal antidote for direct and indirect factor Xa inhibitors [Abstract]J Thromb Haemost201311Suppl 230
   Google Scholar
• CrowtherMMathurVKittMA phase 2 randomized, double-blind, placebo-controlled trial demonstrating reversal of rivaroxaban-induced anticoagulation in healthy subjects by andexanet alfa (PRT064445), an antidote for FXa inhibitorsPoster presented at: 55th ASH Annual Meeting and ExpositionDecember 7–10, 2013New Orleans, LA
   Google Scholar
• HollenbachSJLuGTanSPRT064445 but not recombinant FVIIa reverses rivaroxaban induced anticoagulation as measured by reduction in blood loss in a rabbit liver laceration modelPoster presented at: 54th ASH Annual Meeting and ExpositionDecember 8–11, 2012Atlanta, GA
   Google Scholar
• LaulichtBBakhruSLeeCSmall molecule antidote for anticoagulantsCirculation2012126A11395
   Web of Science ®Google Scholar
• PerospherePER977: an anticoagulant reversal agent2013 Available from: http://perosphere.com/content/research/per977.htmAccessed June 6, 2013
   Google Scholar
• van RynJLitzenburgerTWatermanADabigatran anticoagulant activity is neutralized by an antibody selective to dabigatran in in vitro and in vivo modelsJ Am Coll Cardiol20115714 Suppl 1E1130
   Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSDabigatran versus war-farin in patients with atrial fibrillationN Engl J Med2009361121139115119717844
   PubMed Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSReillyPAWallentinLNewly identified events in the RE-LY trialN Engl J Med2010363191875187621047252
   PubMed Web of Science ®Google Scholar
• GiuglianoRPRuffCTBraunwaldEEdoxaban versus warfa-rin in patients with atrial fibrillationN Engl J Med2013369222093210424251359
   PubMed Web of Science ®Google Scholar
• GrangerCBAlexanderJHMcMurrayJJApixaban versus war-farin in patients with atrial fibrillationN Engl J Med20113651198199221870978
   PubMed Web of Science ®Google Scholar
• PatelMRMahaffeyKWGargJRivaroxaban versus warfa-rin in nonvalvular atrial fibrillationN Engl J Med20113651088389121830957
   PubMed Web of Science ®Google Scholar
• ConnollySJEikelboomJJoynerCApixaban in patients with atrial fibrillationN Engl J Med2011364980681721309657
   PubMed Web of Science ®Google Scholar
• Cruz-FloresSRabinsteinABillerJRacial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke AssociationStroke20114272091211621617147
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionAwareness of stroke warning symptoms – 13 states and the District of Columbia, 2005MMWR Morb Mortal Wkly Rep2008571848148518463605
   PubMedGoogle Scholar
• GreenlundKJNeffLJZhengZJLow public recognition of major stroke symptomsAm J Prev Med200325431531914580633
   PubMed Web of Science ®Google Scholar
• LutfiyyaMNLipskyMSBalesRWChaIMcGrathCDisparities in knowledge of heart attack and stroke symptoms among adult men: an analysis of behavioral risk factor surveillance survey dataJ Natl Med Assoc2008100101116112418942272
   PubMed Web of Science ®Google Scholar
• LutfiyyaMNCumbaMTMcCulloughJEBarlowELLipskyMSDisparities in adult African American women’s knowledge of heart attack and stroke symptomatology: an analysis of 2003–2005 Behavioral Risk Factor Surveillance Survey dataJ Womens Health (Larchmt)200817580581318479229
   PubMed Web of Science ®Google Scholar
• LutfiyyaMNNgLAsnerNLipskyMSDisparities in stroke sympto-mology knowledge among US midlife women: an analysis of population survey dataJ Stroke Cerebrovasc Dis200918215015719251192
   PubMed Web of Science ®Google Scholar
• ZerwicJHwangSYTuccoLInterpretation of symptoms and delay in seeking treatment by patients who have had a stroke: exploratory studyHeart Lung2007361253417234474
   PubMed Web of Science ®Google Scholar
• WilsonFLRacineETekieliVWilliamsBLiteracy, readability and cultural barriers: critical factors to consider when educating older African Americans about anticoagulation therapyJ Clin Nurs200312227528212603561
   PubMed Web of Science ®Google Scholar